Percutaneous Coronary Interventions in the Diabetic Patient Where Do We Stand?

被引：25
|
作者：
Bittl, John A. [1 ]
机构：
[1] Munroe Reg Med Ctr, Munroe Heart & Vasc Inst, Ocala, FL 34471 USA
来源：
CIRCULATION-CARDIOVASCULAR INTERVENTIONS | 2015年 / 8卷 / 04期
关键词：
angioplasty; balloon; coronary; coronary artery disease; diabetes mellitus; stents; LONG-TERM SURVIVAL; ACUTE MYOCARDIAL-INFARCTION; ASSOCIATION TASK-FORCE; ARTERY-BYPASS SURGERY; CARDIOVASCULAR ANGIOGRAPHY; VASCULAR CALCIFICATION; NONDIABETIC PATIENTS; PLATELET INHIBITION; PRACTICE GUIDELINES; AMERICAN-COLLEGE;
D O I：
10.1161/CIRCINTERVENTIONS.114.001944
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：8
相关论文
共 50 条
  • [1] Optimal management of high bleeding risk patients undergoing percutaneous coronary interventions: Where do we stand?
    Dimitriadis, Kyriakos
    Pyrpyris, Nikolaos
    Iliakis, Panagiotis
    Kanatas, Panagiotis
    Theofilis, Panagiotis
    Sakalidis, Athanasios
    Apostolos, Anastasios
    Tsioufis, Panagiotis
    Papanikolaou, Aggelos
    Aznaouridis, Konstantinos
    Aggeli, Konstantina
    Tsioufis, Konstantinos
    JOURNAL OF CARDIOLOGY, 2025, 85 (02) : 79 - 87
  • [2] Retrograde Chronic Total Occlusion Percutaneous Coronary Interventions Where We Stand and Where We Need to Go
    Karmpaliotis, Dimitri
    Masoumi, Amirali
    JACC-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (08) : 843 - 845
  • [3] Percutaneous coronary intervention of saphenous vein grafts: where do we stand?
    Bulluck, Heerajnarain
    Bagur, Rodrigo
    Mamas, Mamas A.
    EUROINTERVENTION, 2018, 14 (02) : 142 - 143
  • [4] Percutaneous Valve Replacement: Where do we stand? Where are we going?
    Roach, Emir Charles
    Gezgen, Gamze
    Gezgen, Baki
    HEALTHMED, 2010, 4 (04): : 955 - 963
  • [5] Endoluminal Bariatric Interventions : Where do we stand ? Where are we going ?
    Unlu, Ozan
    Okoh, Alexis
    Yilmaz, Bulent
    Roach, Emir C.
    Olayan, May
    Shatnawei, Abdullah
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2015, 78 (04) : 415 - 423
  • [6] Fetal cardiac interventions: Where do we stand?
    Friedman, Kevin G.
    Tworetzky, Wayne
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2020, 113 (02) : 121 - 128
  • [7] Nutritional interventions in sarcopenia: where do we stand?
    Woo, Jean
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2018, 21 (01): : 19 - 23
  • [8] Where do we stand on human diabetic nephropathy?
    Cha, Dae Ryong
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2013, 32 (03) : 93 - 95
  • [9] Mitral valve interventions. Where do we stand?
    Frerker, C.
    Schmidt, T.
    Kreidel, F.
    Schlueter, M.
    Kuck, K. -H.
    HERZ, 2015, 40 (05) : 752 - 758
  • [10] The computerized patient record: Where do we stand?
    Jaspers, M. W. M.
    Knaup, P.
    Schmidt, D.
    METHODS OF INFORMATION IN MEDICINE, 2006, 45 : 29 - 39
12345